Moreover, evidence was provided that the expression of the U2AF35 splicing factor which specifically recognizes the 3-end splice site, essential for correct pre-mRNA splicing, is significantly lower in human pancreatic adenocarcinoma and pancreatic cancer cell-lines than in normal pancreatic tissue [26]. This evidence concerns the gene SLU7 and pancreatic adenocarcinoma.